PROCTER & GAMBLE HYGIENE & HEALTH CARE LTD. - 500459 - Related Party Transactions For Six Months Ended December 31, 2021
We are enclosing herewith the Related Party Transactions for six months ended December 31, 2021. Kindly take the same on record and oblige. PROCTER & GAMBLE HYGIENE & HEALTH CARE LTD. - 500459 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for SBI Funds Management Ltd
Procter Gamble Health profit falls by 34% to Rs 45 crore in October-December
The company had reported a profit after tax (PAT) of Rs 68 crore in the October-December period of the last year. PROCTER & GAMBLE HYGIENE & HEALTH CARE LTD. - 500459 - Communication In Respect Of Deduction Of Tax At Source (TDS) On The Amount Of Dividend Income From Procter & Gamble Hygiene And Health Care Limited ('The Company')
This has reference to the disclosure dated February 1, 2022 regarding declaration of an Interim dividend of Rs.95/- per equity share of face value of Rs. 10 each for the Financial Year 2021-22. Enclosed herewith is the communication sent to the shareholders, in respect of deduction of tax at source (TDS) on the amount of Dividend income from the Company.
Procter & Gamble Hygiene December quarter profit down 15% to Rs 212 cr
Procter & Gamble Hygiene and Health Care Ltd on Tuesday reported 15.38 per cent decline in net profit at Rs 212.06 crore for the second quarter ended December 31, 2021. The company, which follows July-June financial year, had posted a net profit of Rs 250.62 crore in the year-ago period, it said in a regulatory filing. However, revenue from operations was higher at Rs 1,092.98 crore during the period under review as against Rs 1,018.44 crore in the same period a year ago. The company's stock on Tuesday settled at Rs 14,816.80 on BSE, up 0.09 per cent from the previous close. Q3FY22 Quarterly Result Announced for Procter & Gamble Hygiene & Healthcare Ltd.
Personal Products company Procter & Gamble Hygiene and Health Care declares Q3FY22 result: Sales up 7% for the quarter ended December 31, 2021 The company delivered sales of Rs 1093 crores, up 7% vs year ago behind the strength of its trusted product portfolio and strong retail execution. Profit After Tax (PAT) was Rs 212 crores, down 15% vs year ago due to lower advertising and promotion investments on brand building in the base period due to the pandemic and commodity cost inflation. For the quarter, both Feminine Care and Health Care businesses grew ahead of their categories. Compared to the corresponding quarter two years ago, prior to the pandemic, company sales are up 27% and profit is up 56% Madhusudan Gopalan, Managing Director, Procter & Gamble Hygiene and Health Care Ltd. said, “In a challenging market environment, we have delivered strong sales growth behind strong brand fundamentals and improved market execution. As the industry faces commodity inflation challenges, we continue to focus on improving productivity by leveraging advertising and promotion analytics, strengthening our product mix and driving supply chain efficiency to drive balanced top and bottom-line growth. We will continue to focus on our strategy of driving superiority and productivity, invest in brand building, enabled by the strength of our organization and culture.” Result PDF PROCTER & GAMBLE HYGIENE & HEALTH CARE LTD. - 500459 - Corporate Action-Board approves Dividend
We are pleased to inform you that the Board of Directors of the Company at its meeting held today, inter alia, have declared an Interim Dividend for the Financial Year 2021-22 of Rs. 95 per Equity Share (Face Value of Rs. 10/- each). The dividend shall be paid on or before February 28, 2022. As informed earlier in our letter dated January 27, 2022, record date for the purpose of eligibility for payment of said Interim Dividend shall be February 9, 2022. Kindly take the same on record and oblige. PROCTER & GAMBLE HYGIENE & HEALTH CARE LTD. - 500459 - Unaudited Financial Results For The Quarter Ended December 31, 2021 And Interim Dividend For Financial Year 2021-22
We are pleased to inform you that at a meeting of the Board of Directors of the Company held today, the Unaudited Financial Results for the quarter ended December 31, 2021 were approved. We are enclosing herewith the following: a. Unaudited Financial Results for the quarter ended December 31, 2021; b. Press Release; c. Limited Review Report in respect of the Unaudited Financial Results for the quarter ended December 31, 2021 furnished by Statutory Auditors of the Company; and PROCTER & GAMBLE HYGIENE & HEALTH CARE LTD. - 500459 - Board Meeting Outcome for Unaudited Financial Results For The Quarter Ended December 31, 2021 And Interim Dividend For Financial Year 2021-22
We are pleased to inform you that at a meeting of the Board of Directors of the Company held today, the Unaudited Financial Results for the quarter ended December 31, 2021 were approved. We are enclosing herewith the following: a. Unaudited Financial Results for the quarter ended December 31, 2021; b. Press Release; c. Limited Review Report in respect of the Unaudited Financial Results for the quarter ended December 31, 2021 furnished by Statutory Auditors of the Company; and Further, we are pleased to inform you that the Board of Directors of the Company at its meeting held today, inter alia, have declared an Interim Dividend for the Financial Year 2021-22 of Rs. 95 per Equity Share (Face Value of Rs. 10/- each). The dividend shall be paid on or before February 28, 2022. As informed earlier in our letter dated January 27, 2022, record date for the purpose of eligibility for payment of said Interim Dividend shall be February 9, 2022. PROCTER & GAMBLE HYGIENE & HEALTH CARE LTD. - 500459 - Fixes Record Date for Interim Dividend
Procter & Gamble Hygiene and Health Care Ltd has informed BSE that the Company has fixed February 09, 2022 as the Record Date for the purpose of Payment of Interim Dividend, if declared.